Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Acute myeloid leukaemia (AML), Blood cancers, Cell type, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Hairy cell leukaemia, High grade lymphoma, Hodgkin lymphoma, Leukaemia, Low grade lymphoma, Lymphoma, Myelodysplastic syndrome (MDS), Myeloma, Non-Hodgkin lymphoma (NHL), Polycythaemia, Thrombocythaemia
Results
Phase 3
This trial looked at using a drug called tranexamic acid to treat low counts caused by cancer.
The trial was open to people with a blood cancer () who had treatment with or a .
The trial was open for people to join between 2015 and 2022. The team published the results in 2024.
You pronounce tranexamic acid as tran-ex-zam-ic ass-id.
Recruitment start: 19 June 2015
Recruitment end: 18 February 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Lise Estcourt
Dr Simon Stanworth
NIHR Clinical Research Network: Cancer
NHS Blood and Transplant (NHSBT)
Australian National Health and Medical Research Council (NHMRC)
Last reviewed: 20 February 2025
CRUK internal database number: 13027
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
